Furthermore, BM-MSCs have been engineered to express tropic factors, such as BDNF [33,41,43], glial-cell-line-derived neurotrophic factor (GDNF) [44,45,46], and nerve growth factor (NGF) [47,48] to improve therapeutic paracrine effects for NDD treatment. This evidence concerns the gene GDNF and Neurodevelopmental delay.